The "Bladder Cancer Diagnostics Market by Test Type, by Stages, by Cancer Type, by End User, and By Region" report has been ...

According to the National Cancer Institute, approximately 40.5% of Americans will be diagnosed with cancer at some point ...

Taking a combination of two drugs including statins could lower cholesterol - and slow the progression of a common cancer, ...

Climate change is increasing the risk of urological diseases, including cancer and kidney conditions, while urological ...

Two enzyme inhibitors join forces in reducing bladder cancer cell proliferation. n 1996, molecular biologist Kun Ping Lu, a ...

Cancer is a leading cause of mortality worldwide, and men above 40 are particularly at risk for certain types. While several ...

Jan. 30—"When the people lead, the leaders follow." That's the mantra being followed by environmental and community advocates who believe more action is needed to protect the public from a potentially ...

KRISTOPHER WENTZEL ONCOLOGY Hematologist Oncologist The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate Dr. Kristopher Wentzel leads the ...

The preeminent expert on the two-century history of what's now known as Albany Academies, McClintock spent decades ...

Sequential gemcitabine docetaxel is increasingly viewed as a valid option for BCG unresponsive non-muscle-invasive bladder cancer (NMIBC).

CARLSBAD, Calif. - Tyra Biosciences , Inc. (NASDAQ:TYRA), a biotech firm specializing in precision medicines targeting Fibroblast Growth Factor Receptor (FGFR) biology, today announced the appointment ...